Related Experiment Video
Updated: Sep 10, 2025

Author Spotlight: Utilizing Traditional Chinese Acupuncture of the Ear to Improve Sleep Disorders
Published on: August 18, 2023
Ocular manifestations in COPD patients. An underrecognized comorbidity.
Maria Dettoraki1, Kalliopi-Theoni Vandorou2, Dionysios Tsoukalas3
12nd Department of Ophthalmology, University Hospital "Attikon", National and Kapodistrian University of Athens, Athens, Greece.
Chronic obstructive pulmonary disease (COPD) is linked to eye conditions affecting vision. This review highlights these underrecognized ocular abnormalities in COPD patients.
Area of Science:
- Ophthalmology
- Pulmonology
- Internal Medicine
Background:
- Chronic obstructive pulmonary disease (COPD) is frequently associated with comorbidities, notably cardiovascular diseases, which significantly influence patient outcomes.
- Patients with COPD may experience age-related conditions, such as macular degeneration and cataracts, at an earlier life stage.
- Growing evidence indicates a connection between COPD and ocular abnormalities, particularly affecting the posterior eye segment, including retinal microvasculature, optic nerve, choroid, and cornea.
Purpose of the Study:
- To comprehensively review and describe the ocular findings associated with COPD, emphasizing its status as an underrecognized comorbidity.
- To introduce pulmonologists to current ophthalmological techniques for assessing ocular microvascular networks, relevant to cardiovascular comorbidities.
Main Methods:
- Literature review synthesizing existing evidence on ocular abnormalities in COPD patients.
- Discussion of ophthalmological assessment techniques applicable to COPD comorbidities.
Main Results:
- COPD is associated with various ocular abnormalities, primarily impacting the posterior segment.
- These abnormalities affect the retinal microvascular network, optic nerve, choroid, and cornea.
- Ocular microvascular changes in COPD patients often correlate with cardiovascular comorbidities.
Conclusions:
- Ocular abnormalities are an underrecognized comorbidity in COPD patients.
- Assessing ocular microvascular networks can provide insights into cardiovascular health in COPD.
- Further research and clinical integration of ophthalmological assessments are encouraged for COPD management.
More Related Videos
04:53Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach
Published on: October 18, 2024
04:03Author Spotlight: Evaluating the Therapeutic Efficacy of Moving Cupping Along Meridians for Acute Exacerbation of COPD
Published on: September 27, 2024
Related Concept Videos
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
COPD: Management Using Bronchodilators and Corticosteroids
Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation